PFM Health Sciences, LP - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 111 filers reported holding CLOVIS ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2018$78,656,000
-44.6%
2,678,128
-14.2%
1.15%
-48.1%
Q2 2018$141,954,000
+681.3%
3,121,925
+1315.9%
2.22%
+522.7%
Q3 2017$18,168,000
-47.6%
220,487
-40.4%
0.36%
-61.8%
Q2 2017$34,656,000
-45.9%
370,141
-63.2%
0.93%
-41.8%
Q1 2017$64,082,000
+12.8%
1,006,472
-21.3%
1.60%
+0.2%
Q4 2016$56,807,000
+105.2%
1,278,855
+66.5%
1.60%
+97.4%
Q3 2016$27,690,000
+1.6%
768,090
-61.3%
0.81%
-1.3%
Q2 2016$27,256,000
-24.3%
1,986,582
+6.0%
0.82%
-25.9%
Q1 2016$35,988,000
-50.5%
1,874,384
-9.8%
1.11%
-49.8%
Q4 2015$72,745,000
-69.0%
2,078,440
-18.6%
2.21%
-66.5%
Q3 2015$234,763,000
-1.6%
2,552,887
-5.9%
6.60%
+9.4%
Q2 2015$238,477,000
+41.7%
2,713,661
+19.7%
6.04%
+30.1%
Q1 2015$168,261,000
+74.2%
2,266,756
+31.4%
4.64%
+105.6%
Q4 2014$96,607,000
+67.7%
1,725,126
+35.8%
2.26%
+70.1%
Q3 2014$57,617,000
+212.9%
1,270,209
+185.6%
1.33%
+260.3%
Q2 2014$18,416,000
-75.3%
444,734
-58.7%
0.37%
-72.8%
Q1 2014$74,591,000
-52.1%
1,076,820
-58.3%
1.35%
-56.8%
Q4 2013$155,708,000
+26.3%
2,583,508
+27.5%
3.13%
+5.5%
Q3 2013$123,236,000
-9.2%
2,026,908
+0.1%
2.97%
+5.3%
Q2 2013$135,665,000
+905.6%
2,025,456
+330.4%
2.82%
+531.8%
Q1 2013$13,491,000470,5620.45%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2013
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$60,485,054,00053.20%
Palo Alto Investors LP 2,121,857$157,505,0007.79%
NEA Management Company, LLC 2,279,781$169,228,0007.65%
EcoR1 Capital, LLC 243,048$18,041,0006.01%
Redmile Group, LLC 900,879$66,872,0006.00%
Opaleye Management Inc. 140,000$10,392,0004.82%
PFM Health Sciences, LP 2,266,756$168,261,0004.64%
Partner Investment Management, L.P. 40,798$3,028,0004.56%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 826,919$61,383,0003.74%
Opus Point Partners Management, LLC 55,988$4,156,0003.48%
View complete list of CLOVIS ONCOLOGY INC shareholders